Nazara Tech plans ₹733.5 cr preferential issue in 2026

What the board approved on August 6, 2026

Nazara Technologies Limited said its board has approved raising about ₹733.5 crore through a preferential issue of equity shares. The proposal is to issue up to 2,39,70,676 equity shares. The issue price is set at ₹306 per share, as per the company’s disclosure. The approval was taken at a board meeting on August 6, 2026. Preferential allotments are typically used to raise capital from a set of identified investors rather than through a public issue. For Nazara, this becomes a fresh equity fundraising plan at a time when it has already been executing a separate preferential warrant programme approved earlier in 2026.

Size, price, and share count: the key terms

The preferential issue approved by the board involves equity shares, not warrants. The company has indicated a ceiling of 2,39,70,676 shares. At ₹306 per share, the aggregate consideration works out to approximately ₹733.5 crore. These terms matter because both the number of shares and the price determine the headline fundraising and the likely dilution for existing shareholders, subject to final allotment. The company has positioned the plan as a capital-raising initiative to strengthen its expansion war chest. No further details on the identity of proposed allottees were included in the provided information.

Authorized capital increase to support the issuance

Alongside the fundraising plan, the board also approved a change in authorized share capital. Nazara said the authorized share capital will be increased from ₹80 crore to ₹90 crore. This step is intended to facilitate the proposed issuance of new equity shares. Companies typically raise authorized capital when they need headroom to issue additional shares beyond existing limits. The move signals that the board is preparing the corporate structure required to complete the transaction after shareholder approval. Any further steps will depend on the approvals process and the eventual allotment.

Shareholder approval: EGM scheduled for August 30, 2026

Nazara has scheduled an Extraordinary General Meeting (EGM) on August 30, 2026 to seek shareholder approval for the preferential issue. An EGM vote is a key procedural step for such transactions under Indian listing and corporate governance frameworks. The EGM outcome will decide whether the company can proceed with the proposed issuance under the stated terms. The board approval on August 6, 2026 establishes the proposal, but the issue cannot be consummated without the necessary member consent. The company’s filings also point to a structured process, with specific meeting dates and an approval pathway laid out in advance.

The earlier board meeting agenda and trading-window restrictions

Separately, Nazara had informed that it would convene a board meeting on Thursday, August 06, 2026 to consider raising capital through a preferential allotment. The proposal under consideration included issuance of equity shares, convertible instruments, or other eligible securities to one or more persons. The subsequent board approval aligns with that agenda. The company also noted that the trading window for designated persons, their immediate relatives, and connected persons remained closed until 48 hours after the announcement of the board meeting’s outcome. Such trading-window closures are common around price-sensitive decisions and are part of insider trading compliance practices.

How this compares with Nazara’s June 2026 preferential warrant allotment

The August 2026 equity-issue plan comes after a preferential warrant exercise that progressed earlier in the year. Nazara completed the preferential allotment of 1,82,31,000 warrants at ₹260 per unit (including a premium of ₹258), according to its regulatory filing dated June 5, 2026. The company collected ₹118.50 crore as the mandatory 25% upfront subscription payment at the time of allotment. If all those warrants are converted into equity shares, the total proceeds are stated as ₹474 crore. The warrant holders can convert in one or more tranches within 18 months from the date of allotment, after paying the remaining 75% of the issue price.

Conversion timeline and forfeiture clause on the warrants

Nazara has stated that the conversion window for the warrants runs for 18 months from June 5, 2026, with a deadline of December 5, 2027. This timeline is important because the eventual equity inflow depends on investors paying the remaining amount and exercising the option to convert. The company also flagged that if warrant holders do not convert within the 18-month period, their rights expire and amounts already paid are forfeited. That clause is typical for warrants and is designed to ensure investors follow through within the stipulated window. It also clarifies that the upfront receipt is not automatically refundable if conversion does not happen. As a result, the warrant programme has defined milestones that will sit alongside any new equity fundraising.

Where the earlier proceeds were planned to be used

Nazara disclosed that the warrant proceeds were earmarked to fund its ₹918 crore acquisition of a 50% controlling stake in Spanish gaming platforms Bluetile Games and BestPlay Systems, signed in March 2026. This provides context for why the company has pursued sizeable fundraising in 2026. The acquisition-linked funding plan shows that capital raising is being aligned to expansion transactions, at least for the earlier issue. For the new ₹733.5 crore equity issue, the provided information only references building an “expansion war chest,” without detailing specific acquisitions or investments. Investors will typically look for such linkages in subsequent disclosures, including EGM documentation and final allotment announcements.

Key facts table: new issue and earlier warrant programme

Market impact: what changes for shareholders and the company

A preferential equity issue of this size can materially increase outstanding shares, subject to final allotment, and therefore can dilute existing holdings. At the same time, it can strengthen the company’s balance sheet by adding cash for expansion and corporate needs, depending on the final use of proceeds. The authorized capital increase indicates the company is creating capacity to issue the proposed shares. The earlier warrant programme adds another layer because conversion, if exercised, would also result in new equity issuance and additional capital inflow. Taken together, these actions show Nazara is actively using capital markets tools in 2026 and 2027 to fund growth initiatives and transactions already announced.

Conclusion: what to watch next

Nazara’s board-backed plan to raise about ₹733.5 crore through a preferential issue at ₹306 per share now moves to shareholders for approval at the August 30, 2026 EGM. The company has also taken enabling steps by increasing authorized share capital from ₹80 crore to ₹90 crore. In parallel, investors will track the ongoing warrant conversion window that runs until December 5, 2027, given the stated ₹474 crore proceeds if fully converted. The next concrete milestone for the new fundraising plan is the EGM vote and any subsequent exchange filings detailing approvals and allotment specifics.